Serina Therapeutics Inc. (SER)
NYSE: SER
· Real-Time Price · USD
5.28
-0.22 (-4.00%)
At close: Aug 15, 2025, 3:59 PM
5.20
-1.52%
After-hours: Aug 15, 2025, 07:49 PM EDT
Serina Therapeutics Cash Flow Statement
Financials in USD. Fiscal
year is
undefined.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -6.46M | -4.82M | -2.75M | 1.38M | 5.2M | -9.44M | -3.46M | -5.4M | -2.67M | -3.28M | -2.7M | -2.44M | -2.62M | -2.71M | -2.16M | -1.96M | -2.48M | -1.99M |
Depreciation & Amortization | 16K | 17K | 56K | 56K | 57K | 25K | 33K | 33K | 32K | 33K | 33K | 33K | 33K | 33K | 33K | 32K | 33K | 33K |
Stock-Based Compensation | 890K | 956K | 988K | 1.1M | 458K | 53K | n/a | n/a | 22.32K | 2K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Working Capital | n/a | 14K | 763K | 221K | -2.74M | 291K | -120K | -390K | 173K | 28K | 133K | 7K | 88K | -64K | 76K | -126K | 51K | -241K |
Other Non-Cash Items | 1.81M | -928K | -2.71M | -6.44M | -8.94M | 7.25M | 3.79M | 3.56M | 1.52M | 1.01M | 804K | 985K | 1.67M | 703K | 776K | 1.01M | 481K | -188K |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | n/a | 455K | -172K | 943K | -4.79M | 535K | -250K | -52K | -331K | 230K | 372K | 127K | -338K | 168K | -78K | -516K | 192K | -482K |
Operating Cash Flow | -3.75M | -4.32M | -4.59M | -2.96M | -8.01M | -1.58M | 121K | -1.86M | -2.02M | -1.86M | -1.32M | -1.24M | -1.75M | -1.64M | -1.65M | -1.88M | -1.69M | -2.63M |
Capital Expenditures | n/a | n/a | -5K | -3K | n/a | -14K | -70K | -119K | -315.34K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 466K | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -466K | 466K |
Other Investing Acitivies | -46K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -10M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -50K |
Investing Cash Flow | -46K | n/a | -5K | -3K | n/a | -14K | -70K | -119K | -315.34K | -10M | n/a | n/a | n/a | n/a | 250K | n/a | n/a | 416K |
Debt Repayment | n/a | n/a | 109K | n/a | 379K | 2.39M | -13K | -12K | 2M | 11.5M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 2.25M |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 5.57M | 1K | 4.92M | n/a | n/a | 337K | n/a | n/a | n/a | n/a | 1.5M | 1M | 2M | 1.5M | 1.25M | 2M | 1.5M | -250K |
Financial Cash Flow | 5.57M | 4.92M | 5.03M | 86K | 5.37M | 2.73M | -13K | 2K | 2M | 11.5M | 1.5M | 1M | 2M | 1.5M | 1.25M | 2M | 1.5M | 2.5M |
Net Cash Flow | n/a | 595K | 437K | -2.88M | -2.64M | 1.14M | 7.22M | 136K | -19K | -365K | 179K | -236K | 254K | -136K | -147K | 116K | -194K | n/a |
Free Cash Flow | -3.75M | -4.32M | -4.59M | -2.96M | -8.01M | -1.59M | -2.05M | -1.86M | -2.33M | -1.86M | -1.32M | -1.24M | -1.75M | -1.64M | -1.65M | -1.88M | -1.69M | -2.63M |